Anti-inflammatory effect of shikonin on cultured astrocytes derived from rat brain

Physiology and Pharmacology

Volumn 16, Issue 2, 2012, Pages 107-120

  Hosseini, Shirin ^a   Sabouni, Farzaneh ^b   Fereidoni, Masoud ^a   Moghimi, Ali ^a  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

Author keywords

Astrocytes; Inflammation; Neurodegenerative disease; NO; Shikonin

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SHIKONIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL DEATH; CELL VIABILITY; IMMUNOCYTOCHEMISTRY; INFANT; LITHOSPERMUM; MTT ASSAY; NONHUMAN; RAT; TOXICITY;

EID: 84922685848     PISSN: 17350581     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Abdi A, Mohagheghi F, Sadraie SH, Dargahi L, Khalaj L, Ahmadiani A, Caspase inhibition in neuroinflammation induced by soluble β amyloid monomer, protects cells from abnormal survival and proliferation, via attenuation of NFκB activity. Physiol Pharmacol 14 (2010) 211-219.
2. Blaise GA, Gauvin D, Gangal M, Authier S, Nitric oxide, cell signaling and cell death. Toxicology 208 (2005) 177-192.
3. Calzado MA, Bacher S, Schmitz ML, NF-κB inhibitors for the treatment of inflammatory diseases and cancer. Curr Med Chem 14 (2007) 367-376.
4. Chang IC, Huang YJ, Chiang TI, Yeh CW, Hsu LS, Shikonin Induces Apoptosis through Reactive Oxygen Species/Extracellular Signal-Regulated Kinase Pathway in Osteosarcoma Cells. Biol Pharm Bull 33 (2010) 816-824.
5. Chen CH, Chern CL, Lin CC, Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 hepatoma cells by shikonin. Planta Med 69 (2003) 1119-1124.
6. Chen X, Yang L, Oppenheim JJ, Zack Howard OM, Cellular Pharmacology Studies of Shikonin Derivatives. Phytother Res 16 (2002) 199-209.
7. Cheng YW, Chang CY, Lin KL, Hu CM, Lin CH, Kang JJ, Shikonin derivatives inhibited LPS-induced NOS in RAW 264.7 cells via downregulation of MAPK/NFkappaB signaling. J Ethnopharmacol 120 (2008) 264-271.
8. Ciapetti G, Cennia E, Pratellia L, Pizzoferrato A, In vitro evaluation of cell/biomaterial interaction by MTT assay. Biomaterials 14 (1993) 359-364.
9. D'Acquisto F, May MJ, Ghosh S, Inhibition of nuclear factor kappa B (NFκB): an emerging theme in anti-inflammatory therapies. Molecular interventions 2 (2002) 22-35.
10. Dong Y, Benveniste EN, Immune Function of Astrocytes. GLIA 36 (2001) 180-190.
11. Festjens N, van Gurp M, van Loo G, Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death. Acta Haematol 111 (2004) 7-27.
12. Griess P, Bemerkungen zu der abhandlung der H.H Weselesky und Benedict: Ueber eining azoverbindungen. Chem Ber 12 (1879) 426-428.
13. Hou Y, Guo T, Wu C, He X, Zhao M, Effect of shikonin on breast cells proliferation and apoptosis in vitro. The Pharmaceutical Society of Japan 126 (2006) 1383-1386.
14. Hsu PC, Huang YT, Tasi ML, Wang YG, Lin JK, Pan MH, Induction of apoptosis by shikonin through coordinative modulation of Bcl-2 family, p27 and p53, release of cytochrome c, and sequential activation of caspase in human colorectal carcinoma cells. J Agricult Food Chem 52 (2004) 6330-6337.
15. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS, Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20 (2000) 6309-6316.
16. Larsen AK, Escargueil AE, Skladanowski A, From DNA damage to G2 arrest: the many roles of topoisomerase II. Prog Cell Cycle Res 5 (2003) 295-300.
17. Liu MH, Lin YS, Sheu SY, Sun JS, Anti-inflammatory effects of daidzein on primary astroglial cell culture. Nutr Neurosci 12 (2009) 123-134.
18. Maragakis NJ, Rothstein JD, Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat ClinPractNeurol 12 (2006) 679-689.
19. McCarthy KD, Vellis JD, Preparation of Separate Astroglial and Oligodandroglial Cell Cultures from Rat Cerebral Tissue. J Cell Biol 85 (1980) 890-902.
20. Murphy S, Production of Nitric Oxide by Glial Cells: Regulation and Potential Roles in the CNS. GLIA 29 (2000) 1-13.
21. Nam KN, Son MS, Park JH, Lee EH, Shikonins attenuate microglial inflammatory responses by inhibition of ERK, Akt, and NF-kB: neuroprotective implications. Neuropharmacol 55 (2008) 819-825.
22. Papageorgiou VP, Assimopoulou AN, Couladouros EA, Hepworth D, Nicolaou KC, The Chemistry and Biology of Alkannin, Shikonin, and Related Naphthazarin Natural Products. AngewChemInt Ed 38 (1999) 270-300.
23. Pelicano H, Carney D, Huang P, ROS stress in cancer cells and therapeutic implications. Drug Resistance 7 (2004) 97-110.
24. Rossi D, Volterra A, Astrocytic dysfunction: Insights on the role in neurodegeneration. Brain Res Bull 80 (2009) 224-232.
25. Saha RN, Pahan K, Signals for the induction of nitric oxide synthase in astrocytes. NeurochemInt 49 (2006) 154-163.
26. Sankawa U, Ebizuka Y, Miyazaki T, Isomura Y, Otsuka H, Antitumor activity of shikonin and its derivatives. Chem Pharm Bull 25 (1977) 2392-2395.
27. Seth P, Koul N, Astrocyte, the star avatar: redefined. J Biosci 33 (2008) 405-421.
28. Silverman N, Maniatis T, NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev 15 (2001) 2321-2342.
29. Sofroniew MV, Vinters HV, Astrocytes: biology and pathology. ActaNeuropathol 119 (2010) 7-35.
30. Stephen J, Crocker RF, Frausto J, Milner R, A Novel Method to Establish Microglia-Free Astrocyte Cultures: Comparison of Matrix Metalloproteinase Expression Profiles in Pure Cultures of Astrocytes and Microglia. GLIA 56 (2008) 1187-1198.
31. Tanaka S, Tajima M, Tsukada M, Tabata M, A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkanin. J Nat Prod 49 (2001) 466-469.
32. Volterra A, Meldolesi J, Astrocytes, from Brain Glue to Communication Elements: The Revolution Continues. Nat Rev Neurosci 6 (2005) 626-640.
33. Wu Z, Wu LJ, Li LH, Tashiro S, Onodera S, Ikejima T, Shikonin regulates HeLa cell death via caspase-3 activation and blockage of DNA synthesis. Natural Prod Res 6 (2004) 155-166.
34. Yingkun N, Lvsong Z, Huimin Y, Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells. J Physiol Pharmacol 88 (2010) 1138-1146.
35. Yoon Y, Kim YO, Lim NY, Jeon WK, Sung HJ, Shikonin, an ingredient of Lithospermum erythrorhizon induced apoptosis in HL60 humam premyelocytic leukemia cell line. Planta Med 65 (1999) 532-535.
36. Yoshida LS, Kawada T, Irie K, Yuda Y, Himi T, Ikemoto F, Takano-Ohmuro H, Shikonin Directly Inhibits Nitric Oxide Synthases: Possible Targets That Affect Thoracic Aorta Relaxation Response and Nitric Oxide Release From RAW 264.7 Macrophages. J Pharmacol Sci 112 (2010) 343-351.
37. Young P, Hernandez MR, Purification of astrocytes from adult human optic nerve heads by immunepanning. Brain Res Brain Res Protoc 12 (2003) 67-76.
38. Zimmermann M, Ethical considerations in relation to pain in animal experimentation. Acta Physiol Scand Suppl. 554 (1986) 221-233.